Top compounds associated with response to FHL1


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.074 0.04
mRNA MI-1 CTRPv2 pan-cancer AAC 0.081 0.04
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.16 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.04
mRNA foretinib GDSC1000 pan-cancer AAC 0.075 0.04
mRNA alvocidib CTRPv2 pan-cancer AAC -0.1 0.04
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.07 0.04
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.081 0.05
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.099 0.05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
Download CSV